Vicriviroc, previously named SCH 417690 and SCH-D, is a pyrimidine CCR5 entry inhibitor of HIV-1. It was developed by the pharmaceutical company Schering-Plough...
17 KB (2,046 words) - 02:22, 27 December 2023
CCR5 receptor antagonist (section Vicriviroc)
with their compound aplaviroc,[citation needed] Schering-Plough with vicriviroc,[citation needed] and Pfizer with maraviroc.[citation needed] All of the...
50 KB (5,518 words) - 03:23, 5 December 2023
Herpes Simplex/Zoster Valganciclovir (Valcyte) Cytomegalovirus (CMV) Vicriviroc HIV-1 Schering-Plough pyrimidine CCR5 entry inhibitor Vidarabine Herpes...
13 KB (513 words) - 18:37, 14 May 2025
tea, appears to interact with gp120 as do several other theaflavins. Vicriviroc, similar to maraviroc, is currently undergoing clinical trials for FDA...
9 KB (1,095 words) - 21:59, 1 December 2024
Vibramycin Vicks Formula 44 Vicodin Es Vicodin Hp Vicodin Vicoprin Vicoprofen vicriviroc (USAN) Victoza Victrelis vidarabine (INN) Vidaza Videx Videx Ec vidofludimus...
8 KB (473 words) - 01:27, 28 March 2025
co-receptor CCR5. These experimental drugs include PRO140 (CytoDyn), Vicriviroc (Phase III trials were cancelled in July 2010) (Schering Plough), Aplaviroc...
67 KB (7,900 words) - 15:35, 19 February 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
4 KB (518 words) - 21:19, 21 November 2023
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
12 KB (1,379 words) - 04:56, 19 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
28 KB (3,133 words) - 05:49, 2 November 2024
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
17 KB (1,895 words) - 07:27, 27 September 2024
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
10 KB (962 words) - 01:22, 25 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
15 KB (1,850 words) - 10:23, 18 March 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
30 KB (2,916 words) - 21:38, 24 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
15 KB (1,735 words) - 21:18, 29 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
101 KB (11,338 words) - 19:50, 22 April 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
15 KB (1,549 words) - 19:18, 3 December 2023
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
20 KB (2,419 words) - 20:40, 6 February 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
20 KB (2,508 words) - 19:36, 5 September 2024
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
10 KB (1,251 words) - 06:53, 3 January 2025
and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120...
29 KB (2,975 words) - 21:50, 23 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
5 KB (518 words) - 01:57, 13 October 2024
modeling of the antiretroviral activity of the CCR5 antagonist vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211). Journal...
13 KB (1,572 words) - 23:39, 18 July 2024
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
28 KB (3,456 words) - 21:43, 16 February 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
14 KB (957 words) - 21:33, 29 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
26 KB (2,934 words) - 23:20, 26 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
2 KB (212 words) - 19:30, 13 October 2022
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
13 KB (1,559 words) - 22:26, 18 March 2025
and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120...
15 KB (1,246 words) - 20:14, 29 May 2025
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
14 KB (1,641 words) - 23:08, 5 September 2024
NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
2 KB (187 words) - 02:49, 17 April 2022